Diagnostic players are focusing on preventative and wellness testing along with bundled testing packages to grow their revenue. For many industry players, these tests now represent around 10-20 percent of their turnover.
Arvind Lal, Executive Chairman of Dr. Lal PathLabs, said in the December quarter, analysts said: “Indian diagnostics sector is undergoing rapid transformation. The increasing burden of non-communicable diseases, as well as newly emerging and existing communicable diseases, increased adoption of evidence-based treatments and a growing emphasis on preventive healthcare diagnostics are expected to support growth momentum.”
Dr. Lal PathLabs already achieves about 20 percent
First print: February 23, 2024 | 8:50 PM IST